Apollo Hospitals Enterprise Limited (APOLLOHOSP) — Financial Results Announcement

· NSE 🔴 High Importance Neutral
Revenue: ₹66,055 CrNet Profit: ₹5,292 Cr
📢 Key Event
Apollo Hospitals reported Q4 FY26 revenue of ₹66,055 million, up 18% YoY, with EBITDA at ₹10,109 million and PAT at ₹5,292 million.
🔄 What Changed
Revenue grew 18% YoY to ₹66,055 million; EBITDA grew 31% to ₹10,109 million; PAT grew 36% to ₹5,292 million; four new hospitals commissioned adding 855 beds at ₹1,590 crore cost; digital health GMV grew 20% to ₹528 crore.
🔮 What's Next
Target annualized revenue of ₹250 billion by Q4 FY27 with EBITDA margin of 6.5%-7.0%; plans to add 3,415 beds by FY29-FY30 at a cost of ₹6,714 crore.
💡 Investor Takeaway
Strong financial growth and strategic expansion signal confidence in long-term value creation for shareholders.

Apollo Hospitals reported consolidated revenue of ₹66,055 million in Q4 FY26, up 18% YoY, with EBITDA rising 31% to ₹10,109 million and PAT growing 36% to ₹5,292 million. The company commissioned four new hospitals adding 855 beds at a cost of ₹1,590 crore and plans to add 3,415 beds by FY29-FY30 at ₹6,714 crore. Digital health GMV grew 20% to ₹528 crore with 11.4% margin, while the platform reached 47 million registered users and 900,000 daily active users. Strategic expansion targets Tier-1 cities and metros, supported by operational metrics across 7,289 stores and 167 diagnostic centers.

📄 View Original Announcement (PDF)

About Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,16,213.95 Cr P/E: 64.5 ROE: 21.9% ROCE: 20.5%

View full APOLLOHOSP stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.